StreetAlpha.app
Home › Stocks › NAUT

Nautilus Biotechnology, Inc. (NAUT)

Healthcare
Members
LATEST PRICE

Nautilus Biotechnology makes the Voyager platform, a system of instruments, consumables and software for measuring proteins in research.

Prices, price targets and earnings estimates for NAUT are shown to AI Starter and AI Pro members. Ratings, flow and news are open to everyone.See plans
AI Auto Pilots
Is NAUT in one of our four AI portfolios? Sign in free to see
See how it works→ Details ↓

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
2 Buy
2firms
2 Buy0 Hold0 Sell
Only 2 firms rated NAUT in the past 90 days, not enough for a consensus
Average 12-month target
Price targets for NAUTThe average, highest and lowest analyst targets and the target chart are shown to AI Starter and AI Pro members.See plans
Latest rating changes
Roth CapitalInitiated
Sep 29Buy
Leerink PartnersInitiated
Sep 9Buy
DateFirmActionRatingPrice target
Sep 29Roth CapitalInitiatedBuy
Sep 9Leerink PartnersInitiatedBuy
Loading…

Whale Options Flow

90D

No whale options trades in NAUT in the last 90 days.

Loading…

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether NAUT is in one of them and how their past NAUT trades turned out.

See how it works→ View all auto pilots→
NAUT in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered NAUT in an article yet. Here's the latest on the wider market.

macronewsFriday, October 30, 2026
Binance and Polymarket Hacks Test Crypto's Plumbing, Not Yet Macro
Binance paused withdrawals after a suspected theft of roughly $6 billion, while Polymarket halted trading for an hour after a vendor breach.
Jean Westart · 3 min read
macronewsMonday, October 26, 2026
S&P 500 Sits 2.5% Below Its Record Ahead of the Fed and Big Tech
The S&P 500 slipped 0.47% to 7,623.68, 2.5% below its record, as the Fed meets October 28 and Alphabet, Microsoft and Amazon report.
Marie Crown · 3 min read
macronewsMonday, October 26, 2026
Hightower's Stephanie Link Tells Investors to Add on Volatility
Hightower's Stephanie Link told CNBC's Squawk Box that investors should use market volatility to add to portfolios as earnings season unfolds.
Adam Landser · 2 min read

About Nautilus Biotechnology

Nautilus Biotechnology is a life sciences company based in Seattle, Washington, that is developing tools for measuring proteins in biological samples. Its Voyager platform combines instruments, consumables and software for proteomics research, with the aim of counting protein and protein variant levels one molecule at a time. The company serves researchers and life science customers. For now it offers analysis services to a limited group of early access customers while it works toward broader commercial sales. Its technology is aimed at drug discovery, biomarker research and precision medicine.

Headquarters
Seattle, WA
Summary based on the company’s 2026 annual report (10-K) ↗